Ad
related to: marinus pharmaceuticals
Search results
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoMarinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q4 2023 Earnings Call Transcript March 5, 2024 Marinus...
Marinus Pharmaceuticals Inc (MRNS) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 7 months agoMarinus Pharmaceuticals Inc (NASDAQ:MRNS) reported a net loss of $32.972 million for Q3 2023,...
Institutional investors are Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) biggest bettors and were...
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Given the large stake in the stock by institutions, Marinus Pharmaceuticals' stock...
What Type Of Shareholders Make Up Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Share Registry?
Simply Wall St. via Yahoo Finance· 2 years agoA look at the shareholders of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) can tell us which group is...
Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Share Price Matching Investor Opinion
Simply Wall St. via Yahoo Finance· 1 year agoYou may think that with a price-to-sales (or "P/S") ratio of 15.6x Marinus Pharmaceuticals, Inc....
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Analysts Just Slashed This Year's Estimates
Simply Wall St. via Yahoo Finance· 2 years agoThe latest analyst coverage could presage a bad day for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS),...
Earnings Release: Here's Why Analysts Cut Their Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Price...
Simply Wall St. via Yahoo Finance· 4 weeks agoMarinus Pharmaceuticals, Inc. (NASDAQ:MRNS) just released its latest first-quarter report and things...
What You Need To Know About The Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Analyst Downgrade Today
Simply Wall St. via Yahoo Finance· 2 years agoToday is shaping up negative for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shareholders, with the...
Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 3 months agoMarinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of -15.63% and 7.58%,...
Marinus Pharmaceuticals (MRNS) Soars 19.9%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 9 months agoMarinus Pharmaceuticals (MRNS) was a big mover last session on higher-than-average trading volume....
